Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health Forum. David Powell, ...

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Drug overdose deaths in the United States decreased from an estimated 110,037 in 2023 to 80,391 in 2024. HealthDay News — Drug overdose deaths decreased by 26.9 percent from 2023 to 2024, according to ...

Gabapentinoids are not associated with risk for self-harm in adults; however, elevated risk is seen before initiation of treatment, during the initial phase of treatment, and after discontinuation of ...

HealthDay News — Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept study published online April 28 in the Journal of Bone & ...

OpenAI has unveiled a large dataset to help test how well artificial intelligence models answer health care questions.

The executive order instructs the U.S. Department of Health and Human Services to align Medicare payments for drugs given in a doctor’s office with the lowest prices paid by other nations. Drug ...

Patients with vs without RA have a higher risk for avoidable hospitalizations for ambulatory care sensitive conditions, particularly heart failure and pulmonary edema.

Maternal RSV vaccination and nirsevimab were associated with a reduction in RSV hospitalization rates in infants aged 0 to 7 months during the 2024-2025 RSV season.

North Dakota is the latest state to find itself dealing with a measles outbreak, becoming the 11th state in the nation to face the challenge.

RNA-1083 vaccine is noninferior and induces higher immune responses than recommended influenza and COVID-19 vaccines against several influenza strains and SARS-CoV-2.